At Symbios Plus, we believe in utilizing all valuable treatment options including newer medications and modalities of treatment. Symbios Plus has taken steps necessary to become a certified Spravato treatment facility.
What is Spravato ®?
Spravato® (esketamine intranasal) is a prescription, FDA-approved nasal spray made up of the chemical esketamine, which is made from ketamine, an anesthetic drug that is also sed to treat depression at subanesthetic doses. It is administered in a healthcare setting.
The Differences Between Spravato and Ketamine:
Spravato® is the only nasal spray formulation of ketamine on the market. The dose of Spravato® and subanesthetic ketamine may vary. One is not necessarily better than the other. Both have a value and utility in the treatment of psychiatric illnesses.
How Spravato® Treatments are Delivered:
Spravato® treatment varies based on an individual’s specific needs, but generally, the treatment includes doses of nasal spray, spaced about 5 minutes apart, under medical supervision in the clinic.
How Long Are Treatments?
Each treatment session lasts approximately two hours, during which patients are monitored in a comfortable, safe, and secure setting. Due to the possible side effects of the treatment, you are NOT permitted to drive yourself home afterwards; you must be picked up by a friend, family member, or ride share service.
Who Could Benefit from Spravato® Treatments?
Spravato® is for adults with treatment-resistant depression (TRD) and major depressive disorder (MDD).
People Who Should Not Try Spravato®:
Spravato® is not approved for use by children. You should not use Spravato® if you are pregnant or plan to become pregnant, have a history of substance abuse, including alcoholism, blood vessel disease or a history of bleeding in the brain, uncontrolled hypertension, or other medical contraindications.
